A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL
スポンサーリンク
概要
- 論文の詳細を見る
We describe a rare case of myelodysplastic syndrome that developed chronic myelogeneous leukemia with acquisition of Philadelphia chromosome. The major BCR/ABL transcript was confirmed by molecular analysis. Shortly thereafter, the patient showed transformation to blastic crisis. Hematological remission was achieved after 3 months of treatment with imatinib mesylate. The patient relapsed with additional chromosomal abnormalities and the disease became refractory to the treatment. Acquisition of the Philadelphia chromosome is an infrequent event in myelodysplastic syndrome, and the addition of this change to the initial genetic abnormality that caused MDS may have been associated with the accelerated clinical course of this patient.
- Springer Berlin / Heidelbergの論文
著者
関連論文
- Incidence and Risk of Postherpetic Neuralgia after Varicella Zoster Virus Infection in Hematopoietic Cell Transplantation Recipients: Hokkaido Hematology Study Group
- Insertion (21;8)(q22;q22q22) : a masked t(8;21) in a patient with acute myelocytic leukemia
- A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- A Surgical Case for Severe Hemolytic Anemia after Mitral Valve Repair
- Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients
- Aleukemic leukemia cutis in a patient with Philadelphia chromosome-positive biphenotypic leukemia.
- Treatment With Low-Dose Cytosine Arabinoside Followed by Administration of Macrophage Colony-Stimulating Factor Prolongs the Survival of Patients With RAEB, RAEB-T, or Leukemic Phase Myelodysplastic Syndrome: A Pilot Study
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies